Quality Improvement Program Cuts Inappropriate CCTA Exams
Applying a systematic continuous quality improvement program can significantly reduce the number of inappropriately recommended coronary CT angiography exams.
Applying a systematic continuous quality improvement (CQI) program can significantly reduce the number of inappropriately recommended coronary CT angiography (CCTA) exams, say researchers in a study published online in the Journal of the American College of Cardiology.
Researchers from Beaumont Hospital in Royal Oak, Mich., undertook a 3.5-year prospective study to define the appropriateness of CCTA exams as part of the Advanced Cardiovascular Imaging Consortium, a statewide CQI initiative sponsored by Blue Cross Blue Shield of Michigan.
A total of 25,287 cases (mean age 58) from 47 participating centers were analyzed before and after a two-year intervention when the sites participated in educational activities that reinforced the appropriate use of CCTA. The sites conducted the continuing education activities as they deemed appropriate for their setting.
The pre-intervention period took place from July 2007 to June 2008, during which the centers were receiving regular CCTA utilization reports as they had been in the past, but no instructions or details on how the tests were to be performed. The follow-up period was from July 2010 to December 2010, again, with no extra information other than the reports.
During the pre-intervention period, the most common appropriate indications for scans included detection of coronary artery disease (CAD) in symptomatic patients who were at low to intermediate risk. Inappropriate scans were for detection of CAD in asymptomatic patients. The most common uncertain indications were patients who were symptomatic but considered to be low risk.
Following the intervention, there was a significant decrease inappropriate orders for CCTA exams, while orders for appropriate CCTA exams increased. Exams for asymptomatic low-risk patients dropped from 73 percent pre-intervention to 57 percent post intervention. Scans among high-risk patients with acute symptoms dropped from 16.7 percent to 13 percent. Appropriate use of scan increased from 75.4 percent to 80 percent.
“The study suggests that voluntary, mutually established quality metrics reinforced by provider education and feedback can succeed in effectuating major changes, with implications extending beyond CCTA,” wrote the authors.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
